欧洲数字治疗市场预测至 2028 年 - COVID-19 影响和应用区域分析 [糖尿病、心血管疾病、中枢神经系统 (CNS) 疾病、呼吸系统疾病、戒烟、肌肉骨骼疾病等] 和分销渠道（患者、提供商） 、付款人和雇主）
No. of Pages: 113 | Report Code: TIPRE00028819 | Category: Technology, Media and Telecommunications
No. of Pages: 113 | Report Code: TIPRE00028819 | Category: Technology, Media and Telecommunications
市场的增长归因于数量的不断增加医疗保健公司以及欧洲各地越来越多的初创企业建立了伙伴关系和合作。然而，与数据安全相关的网络威胁和风险限制了市场的增长。
由于数字疗法提供的好处，它已迅速获得雇主和保险公司的认可。在支持下，市场上出现了各种重要的合作和伙伴关系，推动了数字治疗市场的增长。该市场有大量小型参与者。然而，近几年来，大公司开始对这个市场产生兴趣。例如，2018 年 6 月，Cigna 与 Omada Health 合作。通过此次合作，符合条件的 Cigna 管理的健康计划客户可以免费访问 Omada 的数字强化行为咨询平台，作为健康改善计划组合中全面覆盖的预防福利。 2019 年，领先的数字治疗公司 Propeller Health 与 Orion Corporation 合作，将后者用于哮喘和慢性阻塞性肺病患者的 Easyhaler 系列吸入器连接到 Propeller 的数字医疗平台。 Propeller 的平台涵盖了 90% 以上的哮喘和慢性阻塞性肺病吸入药物。此次合作扩大了 Propeller 在欧洲的业务。该协会通过合作和伙伴关系积极推动数字治疗行业的发展。 2018 年 5 月，DTA 宣布与总部位于马里兰州罗克维尔的非营利组织 USP 建立合作伙伴关系，为数字治疗制定适当的标准和指南。 2018 年 10 月，DTA 通过加入专门从事设计和开发数字治疗和健康解决方案的 S3 Connected Health 扩大了其欧洲会员资格。
数字疗法有助于监测和管理各种慢性疾病，例如糖尿病、心脏病和呼吸道感染。政府采取了各种举措来支持数字治疗市场的增长。因此，政府资助的报销、审批的激增、接受监测的患者数量的增加预计将鼓励初创企业进入数字治疗行业。
2028年欧洲数字治疗市场收入及预测（百万美元）
Strategic insights for Europe Digital Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,023.59 Million |
| Market Size by 2028 | US$ 1,338.13 Million |
| Global CAGR (2021 - 2028) | 22.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Digital Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Digital Therapeutics Market is valued at US$ 1,023.59 Million in 2021, it is projected to reach US$ 1,338.13 Million by 2028.
As per our report Europe Digital Therapeutics Market, the market size is valued at US$ 1,023.59 Million in 2021, projecting it to reach US$ 1,338.13 Million by 2028. This translates to a CAGR of approximately 22.9% during the forecast period.
The Europe Digital Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Digital Therapeutics Market report:
The Europe Digital Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Digital Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Digital Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Digital Therapeutics Market
